Soung, J., Tiu, L., Veverka, K. and Hong, C.-H. (2018) “Patient Preference for Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam or Topical Suspension vs. Latest Topical Treatment in the PSO-INSIGHTFUL Study”, SKIN The Journal of Cutaneous Medicine, 2(S1), p. S10. doi: 10.25251/skin.2.supp.10.